These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with Schistosomiasis. Crosby A, Soon E, Jones FM, Southwood MR, Haghighat L, Toshner MR, Raine T, Horan I, Yang P, Moore S, Ferrer E, Wright P, Ormiston ML, White RJ, Haight DA, Dunne DW, Morrell NW. Am J Respir Crit Care Med; 2015 Dec 01; 192(11):1355-65. PubMed ID: 26308618 [Abstract] [Full Text] [Related]
5. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension. Hautefort A, Mendes-Ferreira P, Sabourin J, Manaud G, Bertero T, Rucker-Martin C, Riou M, Adão R, Manoury B, Lambert M, Boet A, Lecerf F, Domergue V, Brás-Silva C, Gomez AM, Montani D, Girerd B, Humbert M, Antigny F, Perros F. Circulation; 2019 Feb 12; 139(7):932-948. PubMed ID: 30586714 [Abstract] [Full Text] [Related]
7. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation. Tian W, Jiang X, Sung YK, Shuffle E, Wu TH, Kao PN, Tu AB, Dorfmüller P, Cao A, Wang L, Peng G, Kim Y, Zhang P, Chappell J, Pasupneti S, Dahms P, Maguire P, Chaib H, Zamanian R, Peters-Golden M, Snyder MP, Voelkel NF, Humbert M, Rabinovitch M, Nicolls MR. Circulation; 2019 Oct 22; 140(17):1409-1425. PubMed ID: 31462075 [Abstract] [Full Text] [Related]
11. Impaired Interleukin-15 Signaling via BMPR2 Loss Drives Natural Killer Cell Deficiency and Pulmonary Hypertension. Hilton LR, Rätsep MT, VandenBroek MM, Jafri S, Laverty KJ, Mitchell M, Theilmann AL, Smart JA, Hawke LG, Moore SD, Renaud SJ, Soares MJ, Morrell NW, Ormiston ML. Hypertension; 2022 Nov 26; 79(11):2493-2504. PubMed ID: 36043416 [Abstract] [Full Text] [Related]
12. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Cheng G, Wang X, Li Y, He L. Stem Cell Res Ther; 2017 Feb 10; 8(1):34. PubMed ID: 28187784 [Abstract] [Full Text] [Related]
13. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension. Gomez-Puerto MC, van Zuijen I, Huang CJ, Szulcek R, Pan X, van Dinther MA, Kurakula K, Wiesmeijer CC, Goumans MJ, Bogaard HJ, Morrell NW, Rana AA, Ten Dijke P. J Pathol; 2019 Nov 10; 249(3):356-367. PubMed ID: 31257577 [Abstract] [Full Text] [Related]
14. Rescuing the BMPR2 signaling axis in pulmonary arterial hypertension. West J, Austin E, Fessel JP, Loyd J, Hamid R. Drug Discov Today; 2014 Aug 10; 19(8):1241-5. PubMed ID: 24794464 [Abstract] [Full Text] [Related]
16. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension. Hong KH, Lee YJ, Lee E, Park SO, Han C, Beppu H, Li E, Raizada MK, Bloch KD, Oh SP. Circulation; 2008 Aug 12; 118(7):722-30. PubMed ID: 18663089 [Abstract] [Full Text] [Related]